The annual public report from the Joint Drug Prevention and Treatment Program’s Independent Program Administrator has been released by Major League Baseball. The stats:
- There were 5,391 total drug tests. 4,022 were urine samples, 1,369 were blood samples;
- There were eight positive tests resulting in discipline. All were for stimulants. Seven of the stimulant tests were for Adderall. One for Methylhexaneamine. I guess that means that there are no more steroids in baseball. Yay!
- There were 13 “non-analytical positives.” That’s baseball code for “Biogenesis dudes.”
- There were 122 therapeutic use exemptions for otherwise banned drugs. 119 of them were for ADD drugs like Adderall. Three were three for hypogonadism. A couple of years ago here was only one for hypogonadism, so that’s on the uptick. On the bright side, two years ago there was a therapeutic use exemption for narcolepsy and now there is none. So the narcoleptic either got better or retired.
The most interesting thing here, to me anyway, continues to be the number of Adderall-users in baseball. It’s estimated that 4.7% of the adult population has ADD. 119 of roughly 1,200 major leaguers on 40-man rosters puts the ADD rate at nearly 10%. Back that number down a little bit for the various guys that shuffle in and out of 400-man rosters and you figure that baseball players have ADD diagnosis at around twice the level of that in the normal population.
Are baseball players more likely to have ADD than the rest of the adult population? Are they just more likely to be diagnosed that way? Or are therapeutic use exemptions for ADD drugs a means of getting something ballplayers have always found beneficial — stimulants — in a legal way?
Tacoma Rainiers’ broadcaster Mike Curto reports that the White Sox have acquired veteran right-handed relievers Mark Lowe and Jean Machi from the Mariners in exchange for cash considerations. Neither team has officially confirmed the deal yet.
Lowe, 34, signed a minor league deal with the Mariners in late March. He pitched to a 6.23 ERA in Triple-A Tacoma and tacked on a 4.6 BB/9 and 8.5 SO/9 through 39 innings. He last appeared in the majors with the Tigers, and finished his run in 2016 with a 7.11 ERA through 49 1/3 innings before getting released by the club prior to the 2017 season.
Machi, 35, struggled to find a place in the Mariners’ bullpen this season. A nerve issue in his thumb derailed his efforts at the start of 2017, and he was outrighted to Triple-A after pitching to a 1.17 ERA through 7 2/3 innings in Seattle. In Tacoma, the right-hander’s numbers weren’t too shabby: he split his efforts between the rotation and bullpen and worked a collective 3.44 ERA, 2.0 BB/9 and 7.1 SO/9 through 36 2/3 innings.
Lowe and Machi will help flesh out a White Sox bullpen that has been depleted by recent injuries and trades. They’re expected to report to Chicago’s Triple-A affiliate in Charlotte and could see time in the big leagues by the end of the season.
Yoenis Cespedes told Susan Slusser of the San Francisco Chronicle that he wants to finish his career with the Athletics, according to an exclusive interview released on Friday. The Mets’ 31-year-old outfielder praised Oakland manager Bob Melvin, telling Slusser, “I don’t think there’s a better manager than Melvin” and adding that while he didn’t know if a return to Oakland would be possible, his love for the city had not faded.
Melvin, for his part, said he wasn’t surprised that the slugger wants another go-round with his first major league club, even if only as a final hurrah. Cespedes hit well over two and a half seasons with the A’s, compiling a cumulative .262/.318/.470 batting line from 2012 to 2014 and enjoying two postseason runs with the club before he was traded for Jon Lester and Jonny Gomes in 2014.
There’s been relatively little for Cespedes to complain about since his departure from Oakland, of course: he turned in a career-best performance in 2015, slashing .291/.328/.542 with 35 home runs and 6.7 fWAR in back-to-back gigs with the Tigers and Mets, and netted a whopping three-year, $75 million contract prior to the 2016 season. Still, there’s something special about the A’s, as the slugger relayed to teammate Jerry Blevins:
I told Blevins, ‘I don’t know how many years I’m going to play, but I’m going to play the last year of my career with Oakland.’ I don’t know if that’s possible or not, but that’s my goal.
Whether or not Cespedes gets his wish, it’s unlikely he’ll pursue any kind of deal with the A’s for the time being. He’s still owed $23.75 million in 2017 and 2018 and isn’t scheduled to hit free agency until 2019.